Skip to main content
TipRanks
Go Ultimate75% OFF

Dong Wha Pharm Co., Ltd. (000020) Stock Statistics & Valuation Metrics

Total Valuation

Dong Wha Pharm Co., Ltd. has a market cap or net worth of KRW 137.62B. The enterprise value is KRW 229.30B.

Market Cap
KRW 137.62B
Enterprise Value
KRW 229.30B

Share Statistics

Dong Wha Pharm Co., Ltd. has 27,931,470 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
27,931,470
Owned by Insiders
―
Owned by Institutions
0.55%

Financial Efficiency

Dong Wha Pharm Co., Ltd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is -0.10%.

Return on Equity (ROE)
0.02
Return on Assets (ROA)
0.01
Return on Invested Capital (ROIC)
-0.10%
Return on Capital Employed (ROCE)
-0.00
Revenue Per Employee
592.36M
Profits Per Employee
10.37M
Employee Count
838
Asset Turnover
0.77
Inventory Turnover
2.99

Valuation Ratios

The current PE Ratio of Dong Wha Pharm Co., Ltd. is 7.52. Dong Wha Pharm Co., Ltd.’s PEG ratio is 0.06.

PE Ratio
7.52
PS Ratio
0.26
PB Ratio
0.34
Price to FCF
3.77
Price to Operating Cash Flow
2.70
PEG Ratio
0.06

Income Statement

In the last 12 months, Dong Wha Pharm Co., Ltd. had revenue of 496.39B and earned 8.69B in profits. Earnings per share was 313.37.

Revenue
496.39B
Gross Profit
203.33B
Operating Income
-809.25M
Pretax Income
6.00B
Net Income
8.69B
EBITDA
21.16B
Earnings Per Share (EPS)
313.37

Cash Flow

In the last 12 months, operating cash flow was 49.69B and capital expenditures -14.04B, giving a free cash flow of 35.66B billion.

Operating Cash Flow
49.69B
Free Cash Flow
35.66B
Free Cash Flow per Share
1286.41

Dividends & Yields

Dong Wha Pharm Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 5.06%

Dividend Per Share
―
Dividend Yield
5.06%
Payout Ratio
N/A
Free Cash Flow Yield
26.55%
Earnings Yield
13.30%

Stock Price Statistics

Beta
-0.00
52-Week Price Change
-21.60%
50-Day Moving Average
5213.10
200-Day Moving Average
5496.16
Relative Strength Index (RSI)
34.08
Average Volume (3m)
241.97K

Important Dates

Dong Wha Pharm Co., Ltd. upcoming earnings date is Mar 23, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 16, 2026
Next Earnings Date
Mar 23, 2027
Ex-Dividend Date
―

Financial Position

Dong Wha Pharm Co., Ltd. as a current ratio of 1.07, with Debt / Equity ratio of 31.20%

Current Ratio
1.07
Quick Ratio
0.59
Debt to Market Cap
0.59
Net Debt to EBITDA
4.97
Interest Coverage Ratio
-0.18

Taxes

In the past 12 months, Dong Wha Pharm Co., Ltd. has paid 2.16B in taxes.

Income Tax
2.16B
Effective Tax Rate
0.36

Enterprise Valuation

Dong Wha Pharm Co., Ltd. EV to EBITDA ratio is 4.91, with an EV/FCF ratio of 5.94.

EV to Sales
0.41
EV to EBITDA
4.91
EV to Free Cash Flow
5.94
EV to Operating Cash Flow
4.26

Balance Sheet

Dong Wha Pharm Co., Ltd. has KRW 49.26B in cash and marketable securities with KRW 118.32B in debt, giving a net cash position of -KRW 69.06B billion.

Cash & Marketable Securities
KRW 49.26B
Total Debt
KRW 118.32B
Net Cash
-KRW 69.06B
Net Cash Per Share
-KRW 2,472.65
Tangible Book Value Per Share
KRW 12.07K

Margins

Gross margin is 40.42%, with operating margin of 3.93%, and net profit margin of 3.43%.

Gross Margin
40.42%
Operating Margin
3.93%
Pretax Margin
2.18%
Net Profit Margin
3.43%
EBITDA Margin
8.27%
EBIT Margin
3.93%

Analyst Forecast

The average price target for Dong Wha Pharm Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
5.65%
EPS Growth Forecast
135.25%

Scores

Smart Score
―
AI Score
60